Parkinson’s disease and translational research
نویسندگان
چکیده
منابع مشابه
Translational research in pediatric pulmonary disease, 2017
As readers of this journal know, translational research is the application of basic science findings to improve clinical care; a process that was once called "bench-to-bedside" research. In my field of pediatric pulmonary disease, the rapid advancement of basic science understanding into improved clinical care has been, to use an appropriate term, breathtaking. In this perspective article, I wi...
متن کاملDisease advocacy organizations catalyze translational research
Disease advocacy organizations have long played an important role in the continuum from basic science to therapy development in rare disease research. PXE International has led the field in innovative ways, venturing into specific activities that have traditionally been conducted by scientists. As lay founders, we have engaged in gene discovery, gene patenting, diagnostic test development, epid...
متن کاملKey Challenges in Rheumatic and Musculoskeletal Disease Translational Research
Biotherapeutics have greatly advanced the world of medicine, and and metabolomics for the analysis of blood and tissue has opened products such as monoclonal antibodies, fusion proteins and receptor antagonists have transformed the therapeutic armamentarium for rheumatic and musculoskeletal diseases (RMD) in the last 20 years. Biological understanding of a disease can result in novel targeted t...
متن کاملParkinsons Disease Classification using Neural Network and Feature Selection
In this study, the Multi-Layer Perceptron (MLP)with Back-Propagation learning algorithm are used to classify to effective diagnosis Parkinsons disease(PD).It’s a challenging problem for medical community.Typically characterized by tremor, PD occurs due to the loss of dopamine in the brains thalamic region that results in involuntary or oscillatory movement in the body. A feature selection algor...
متن کاملBasic and translational research
Weinblatt ME, Bingham CO, Mendelsohn AM, et al. Ann Rheum Dis (2012). doi:10.1136/annrheumdis-2012-201411 1 of 9 and anti-TNF-experienced4 patients with RA when administered monthly via subcutaneous injection. Intravenous administration of golimumab every 12 weeks (q12 weeks) was previously assessed in a phase 3 trial in patients with RA, with persistent disease despite MTX therapy.5 While the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Translational Neurodegeneration
سال: 2020
ISSN: 2047-9158
DOI: 10.1186/s40035-020-00223-0